FDA Panel: Expand Use of Fish Oil Drug Vascepa
Research shows drug can reduce rates of dangerous cardiovascular events in high-risk patients.
Cardiovascular Disease
AHA: Lower-Target LDL Level Beneficial After Stroke, TIA
Subsequent risk for CV events lower among patients with ischemic stroke, TIA, evidence of atherosclerosis who target a low-density lipoprotein (LDL) cholesterol level of less than 70 mg/dL.
Kidney Stone Formers Have Worse PCI Outcomes
A history of kidney stones among patients undergoing percutaneous coronary intervention is associated with higher in-hospital mortality and 1- and 3-year myocardial infarctions risks.
Metabolic Acidosis Ups Cardiovascular Risks in CKD Patients
In a study, serum bicarbonate levels less than 22 mEq/L were associated with an increased incidence of major adverse cardiovascular events.
Cardiac Biomarkers May ID High CV Risk in Patients With CKD
In population-based sample, CKD linked to increased risk for MI, composite cardiovascular outcome.
One-Third of CVD in Blacks Attributable to Hypertension
Authors say efforts to maintain normal blood pressure may cut cardiovascular disease.
FDA Fast-Tracks Therapy for Patients at Risk for Acute Kidney Injury After CABG/Valve Surgery
The FDA has granted Fast Track designation to ASP1128, an investigational treatment for patients at increased risk of developing moderate to severe acute kidney injury (AKI) after coronary artery bypass and/or valve (CABG/V) surgery.
Frequent Alcohol Drinking May Up Risk for New-Onset A-Fib
Amount of alcohol intake per drinking session was not associated with new-onset atrial fibrillation.
CVD Risk Declines When BP Meds Taken at Bedtime
Patients routinely taking antihypertensive meds at bedtime have lower risk for CV events, death
Most Cardiovascular Disease Deaths Now Occur at Home
In 2017, 27.3 percent of CVD deaths occurred in the hospital, while 30.9 percent occurred at home
Next post in Cardiovascular Disease (CVD)
